医学
内固定
置信区间
优势比
射线照相术
逻辑回归
口腔正畸科
固定(群体遗传学)
风险因素
外科
牙科
内科学
人口
环境卫生
作者
Tatsuya Fujii,S. Nakayama,Masahiko Hara,Wataru Koizumi,Takeshi Itabashi,Masahito Saito
出处
期刊:JB & JS open access
[Journal of Bone and Joint Surgery]
日期:2017-11-02
卷期号:2 (4): e0022-e0022
被引量:35
标识
DOI:10.2106/jbjs.oa.16.00022
摘要
Background: Six risk factors for screw cutout after internal fixation of intertrochanteric fractures have been reported. The purpose of the present study was to evaluate and compare the impact of the 6 risk factors of screw cutout to clarify the most important one. Methods: We enrolled 8 consecutive patients who had screw cutout and 48 random control subjects after internal fixation of intertrochanteric fractures treated with proximal femoral nail antirotation systems at our institution. All of the patients were female. The group that had screw cutout and the control group were retrospectively evaluated and compared with respect to the OTA/AO classification, presence of a posterolateral fragment, types of reduction pattern on anteroposterior and lateral radiographic images, position of the screw, and the presence of a tip-apex distance (TAD) of ≥20 mm. The impact of each factor on screw cutout was assessed using backward stepwise multivariable logistic regression analysis with the Akaike information criterion. Risk stratification was assessed using classification and regression tree (CART) analysis. Results: Among 6 risk factors, only a TAD of ≥20 mm had a significant impact on screw cutout, with an adjusted odds ratio of 12.4 (95% confidence interval, 1.6 to 129.0; p = 0.019). CART analysis also demonstrated that a TAD of ≥20 mm was the most important risk stratification factor (p < 0.001). Conclusions: Among the 6 previously reported screw cutout-related factors, only a TAD of ≥20 mm was associated with screw cutout after internal fixation of intertrochanteric fractures with proximal femoral nail antirotation systems. Level of Evidence: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.
科研通智能强力驱动
Strongly Powered by AbleSci AI